Ledger.Open graph →
SEC Form D · filed December 16, 2014

SynerGene Therapeutics, Inc

Offering
$7.2M
Sold
$6.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
POTOMAC, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Maria M. Ruiz · POTOMAC, MDExecJames Hsu · POTOMAC, MDDirectorSamuel Chang · POTOMAC, MDDirectorMaria M. Ruiz · POTOMAC, MDExecJames Hsu · POTOMAC, MDDirectorSamuel Chang · POTOMAC, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗